receptor activator nuclear factor κ b rank also known trance receptor member tumor necrosis factor receptor tnfr molecular subfamily rank receptor rankligand rankl part rankranklopg signaling pathway regulates osteoclast differentiation activation associated bone remodeling repair immune cell function lymph node development thermal regulation mammary gland development osteoprotegerin opg decoy receptor rankl regulates stimulation rank signaling pathway competing rankl cytoplasmic domain rank binds trafs transmit signals downstream targets nfκb jnk rank constitutively expressed skeletal muscle thymus liver colon small intestine adrenal gland osteoclast mammary gland epithelial cells prostate vascular pancreas commonly activation nfκb mediated rankl overexpression rank alone sufficient activate nfκb rankl receptor activator nuclear factor κ b ligand found surface stromal cells osteoblasts mutations affecting rank associated infantile malignant osteopetrosis humans mice rank amino acid type transmembrane protein extracellular domain consists amino acids transmembrane domain amino acids cytoplasmic domain consists amino like members tnfr family four extracellular cysteinerich pseudorepeat domains crds shares amino acid identity rank encoded human chromosome shows homology mouse human two monomers rank related noncrystallographic symmetry perpendicular long axis molecules asymmetric unit rank contains four crds spanning length angstroms makes longest member tnfr family binding rankl rank trimerizes receptor activates signaling pathway rankrankl complex forms heterohexameric complex two four rank crds direct contact rankl majority complexs residues hydrophilic unlike members tnfsf surface interaction rankrankl shown imperative rankrelated osteoclastogenesis rankl binds rank binds stimulates activation cjun nterminal kinase jnk nuclear factor kappab nfκb pathways trigger differentiation activation osteoclasts system balanced relative expression opg rankl highly regulated many factors including hormones immune signals growth factors overexpression rankl cause overproduction activation osteoclasts break bone balance rankl opg target therapy many diseases including estrogen deficiencyassociated osteoporosis rheumatoid arthritis pagets disease periodontal disease bone tumors rank also shown key thermoregulation signaling females seems regulated ovarian sex hormones rank expressed key regions brain associated thermoregulation inactivation rank regions causes loss fever response increased levels rankl also shown critical mediator fever response lipopolysaccharideinduced fever proinflammatory cytokines tnfa key role rankrankl system may link osteoporosis hot flashes seen symptoms hormonal changes postmenopausal rank constitutively expressed mammary epithelial tissues calcium transferred mother fetus neonate provided degradation female bone increased osteoclastic activity regulated rankrankl axis rankl also works rank provide proliferative survival signals promote final stages lactating mammary gland development dysfunctional rank rankl causes arrest differentiation expansion alveolar bunds mature lobuloalveolar mammary structures disabling production rank rankl reported expressed breast cancer prostate cancer cell lines rankl expression infiltrating cells within mammary carcinomas activate rankexpressing neoplastic mammary epithelial cells stimulate metastasis expression rankl cells expression rank bone cells may biological presentation pagets seed soil idea affinity rank rankl may reason cancers tend metastasize bone tumor seeded bone tumor cells stimulate bone resorption secreting factors rankl prompting surrounding stroma express growth factors growth factors upregulate production rankl leads osteoclastogenesis bone destruction destruction bone releases growth factors rankl induces osteoclastogenesis triggering vicious cycle bone destruction seen metastatic bone therapies target rankranklopg axis aim either downregulate expression rankl upregulate expression decoy receptor opg example denosumab fully human monoclonal antibody directed rankl phase ii trials denosumab led decrease bone resorption multiple myeloma prostate cancer breast cancer another study looked developing small mimetics based structure opg bind rank well rankl cause defective coupling rank shown interact article incorporates text united states national library medicine public domain httpsenwikipediaorgwikirank